CEBINA reports positive findings on the potency of azelastine, a widely used anti-histamine, as anti-COVID-19 approach

VIENNA, Sept. 17, 2020 /PRNewswire/ -- CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy nasal spray medication containing azelastine has potent efficacy against...